Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2026-01-01 @ 3:02 AM
Study NCT ID:
NCT01284868
Status:
COMPLETED
Last Update Posted:
2013-07-03
First Post:
2011-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2009-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-23
First Submit QC Date:
None
Study First Post Date:
2011-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-01
Last Update Post Date:
2013-07-03
Last Update Post Date Type:
ESTIMATED